首页> 外国专利> POLYPEPTIDE HAVING TERMINAL SUBSTITUTED BY AN ALPHA-SUBSTITUTED ACETIC ACID, THE SUBSTITUENT BEING A XANTHENE, THIOXANTHENE OR DIBENZOCYCLOHEPTENE DERIVATIVE

POLYPEPTIDE HAVING TERMINAL SUBSTITUTED BY AN ALPHA-SUBSTITUTED ACETIC ACID, THE SUBSTITUENT BEING A XANTHENE, THIOXANTHENE OR DIBENZOCYCLOHEPTENE DERIVATIVE

机译:多肽具有被ALPHA取代的乙酸取代的末端,该取代基为黄嘌呤,硫杂蒽或二苯并环庚烯衍生物

摘要

Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, atherosclerotic disorders including Raynaud's disease, restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, ischemic bowel disease, and diabetes. In the claimed new compounds, the N-terminal 16-His is replaced by a building-block of formula ( alpha ).
机译:描述了新型的内皮素拮抗剂及其制备方法和药物组合物,可用于治疗内皮素水平升高,急性和慢性肾衰竭,高血压,心肌梗塞,代谢,内分泌,神经系统疾病,充血性心力衰竭,内毒素性休克,蛛网膜下腔出血,心律不齐,哮喘,先兆子痫,动脉粥样硬化性疾病,包括雷诺氏病,再狭窄,心绞痛,癌症,肺动脉高压,缺血性疾病,胃粘膜损害,出血性休克,缺血性肠病和糖尿病。在所要求保护的新化合物中,N-末端的16-His被式(α)的结构单元所代替。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号